Literature DB >> 16699015

Recombinant adenoviral vectors can induce expression of p73 via the E4-orf6/7 protein.

Gary S Shapiro1, Crystal Van Peursem, David A Ornelles, Jerome Schaack, James DeGregori.   

Abstract

Despite the utility of recombinant adenoviral vectors in basic research, their therapeutic promise remains unfulfilled. Most engineered adenoviral vectors use a heterologous promoter to transcribe a foreign gene. We show that adenoviruses containing the cytomegalovirus immediate-early promoter induce the expression of the proapoptotic cellular protein TAp73 via the cyclin-dependent kinase-retinoblastoma protein-E2F pathway in murine embryonic fibroblasts. Cells transduced with these vectors also expressed high levels of the adenoviral E4-orf6/7 and E2A proteins. By contrast, adenoviruses containing the ubiquitin C promoter failed to elicit these effects. E4-orf6/7 is necessary and sufficient for increased TAp73 expression, as shown by using retrovirus-mediated E4-orf6/7 expression and adenovirus with the E4-orf6/7 gene deleted. Activation of TAp73 likely occurs via E4-orf6/7-induced dimerization of E2F and subsequent binding to the inverted E2F-responsive elements within the TAp73 promoter. In addition, adenoviral vectors containing the cytomegalovirus immediate-early promoter, but not the ubiquitin C promoter, cooperated with chemotherapeutic agents to decrease cellularity in vitro. In contrast to murine embryonic fibroblasts, adenoviruses containing the ubiquitin C promoter, but not the cytomegalovirus immediate-early promoter, induced both E4-orf6/7 and TAp73 in human foreskin fibroblasts, emphasizing the importance of cellular context for promoter-dependent effects. Because TAp73 is important for the efficacy of chemotherapy, adenoviruses that increase TAp73 expression may enhance cancer therapies by promoting apoptosis. However, such adenoviruses may impair the long-term survival of transduced cells during gene replacement therapies. Our findings reveal previously unknown effects of foreign promoters in recombinant adenoviral vectors and suggest means to improve the utility of engineered adenoviruses by better controlling their impact on viral and cellular gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699015      PMCID: PMC1472169          DOI: 10.1128/JVI.02016-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Differential regulation of E2F1 apoptotic target genes in response to DNA damage.

Authors:  Natalia Pediconi; Alessandra Ianari; Antonio Costanzo; Laura Belloni; Rita Gallo; Letizia Cimino; Antonio Porcellini; Isabella Screpanti; Clara Balsano; Edoardo Alesse; Alberto Gulino; Massimo Levrero
Journal:  Nat Cell Biol       Date:  2003-06       Impact factor: 28.824

2.  Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems.

Authors:  S Swift; J Lorens; P Achacoso; G P Nolan
Journal:  Curr Protoc Immunol       Date:  2001-05

Review 3.  Inactivating intracellular antiviral responses during adenovirus infection.

Authors:  Matthew D Weitzman; David A Ornelles
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

4.  Distinct roles for E2F proteins in cell growth control and apoptosis.

Authors:  J DeGregori; G Leone; A Miron; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  The adenovirus E4orf6 protein inhibits DNA double strand break repair and radiosensitizes human tumor cells in an E1B-55K-independent manner.

Authors:  Lori S Hart; Steven M Yannone; Christine Naczki; Joseph S Orlando; Stephen B Waters; Steven A Akman; David J Chen; David Ornelles; Constantinos Koumenis
Journal:  J Biol Chem       Date:  2004-10-26       Impact factor: 5.157

6.  Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.

Authors:  Kenneth P Olive; David A Tuveson; Zachary C Ruhe; Bob Yin; Nicholas A Willis; Roderick T Bronson; Denise Crowley; Tyler Jacks
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

7.  Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

Authors:  Gene A Lang; Tomoo Iwakuma; Young-Ah Suh; Geng Liu; V Ashutosh Rao; John M Parant; Yasmine A Valentin-Vega; Tamara Terzian; Lisa C Caldwell; Louise C Strong; Adel K El-Naggar; Guillermina Lozano
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

8.  Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.

Authors:  L Van Parijs; Y Refaeli; J D Lord; B H Nelson; A K Abbas; D Baltimore
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

9.  Adenoviral-mediated gene transfer in lymphocytes.

Authors:  R P Leon; T Hedlund; S J Meech; S Li; J Schaack; S P Hunger; R C Duke; J DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

10.  Adenovirus vector E4 gene regulates connexin 40 and 43 expression in endothelial cells via PKA and PI3K signal pathways.

Authors:  Fan Zhang; Joseph Cheng; George Lam; David K Jin; Loïc Vincent; Neil R Hackett; Shiyang Wang; Lauren M Young; Barbara Hempstead; Ronald G Crystal; Shahin Rafii
Journal:  Circ Res       Date:  2005-04-14       Impact factor: 17.367

View more
  4 in total

1.  Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors.

Authors:  Jerome Schaack; Michael L Bennett; Gary S Shapiro; James DeGregori; James L McManaman; John W Moorhead
Journal:  Virology       Date:  2011-01-20       Impact factor: 3.616

2.  Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.

Authors:  Mark A Gregory; Tzu L Phang; Paolo Neviani; Francesca Alvarez-Calderon; Christopher A Eide; Thomas O'Hare; Vadym Zaberezhnyy; Richard T Williams; Brian J Druker; Danilo Perrotti; James Degregori
Journal:  Cancer Cell       Date:  2010-07-13       Impact factor: 31.743

3.  Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.

Authors:  Deborah L Burkhart; Stacey E Wirt; Anne-Flore Zmoos; Michael S Kareta; Julien Sage
Journal:  PLoS Genet       Date:  2010-06-24       Impact factor: 5.917

4.  Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression.

Authors:  Jason Lamontagne; Joshua C Mell; Michael J Bouchard
Journal:  PLoS Pathog       Date:  2016-02-18       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.